Ventriculo-lumbar perfusion in acute ischemic stroke

Neurocritical Care

Volumn 5, Issue 1, 2006, Pages 21-29

  Bell, Rodney D ^a   Powers, Barbara L ^b   Brock, David ^a   Provencio, J Javier ^a,c   Flanders, Adam ^a   Benetiz, Ronald ^a   Rosenwasser, Robert ^a   Strause, Jamie ^a   Frazer, Glenn ^b   Kramer, Michael S ^b   Hesson, David ^b   Barnitz, James ^b   Osterholm, J L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Integra LifeSciences Holdings Corporation   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Artificial spinal fluid; Brain perfusion; Intracranial pressure; Ischemic stroke; Lumbar catheter; Oxygenated fluorocarbon

Indexed keywords

FLUOROCARBON;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN PERFUSION; BRAIN VENTRICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUTRIENT CONTENT; OXYGENATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SCORING SYSTEM;

ACUTE DISEASE; ADULT; BRAIN; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CATHETERS, INDWELLING; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID; FEASIBILITY STUDIES; FEMALE; FLUOROCARBONS; HEART-LUNG MACHINE; HEMODYNAMIC PROCESSES; HUMANS; INTRACRANIAL HYPERTENSION; LUMBOSACRAL REGION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748623794     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:5:1:21     Document Type: Article

References (48)

1. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology 1995;45:10-14.
2. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-1517.
3. Sacco RL. Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology 1997;49:S39-S44.
4. Adams HP, Brott TG, Furlan AJ, et al. Stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 1996;94:1167-1174.
5. Morgenstern LB. rtPA in acute ischemic stroke: the North American perspective. Neurology 1997;49:S63-S65.
6. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue Plasminogen Activator for Acute Ischemic Stroke. New Eng J Med 1995;333:1581-1587.
7. Minematsu K, Yamaguchi T, Omae T. Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157-162.
8. Hacke W. rtPA in acute ischemic stroke. European perspective. Neurology 1997;49:60-62.
9. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? N Engl J Med 1997;337:1309-1310.
10. Grotta J. t-PA- the best current option for most patients. N Eng J Med 1997;337:1310-1313.
11. Furlan AJ, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. JAMA 1999;282:2003-2011.
12. Schwab S, Schwarz S, Spanger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461-2466.
13. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999;30:297-292.
14. Hossman K-A, Ophoff BG. Recovery of monkey brain after prolonged ischemia. I. Electrophysiology and brain electrolytes. J Cereb Blood Flow Metab 1986;6:15-21.
15. Hossman K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-565.
16. Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW. Mass effect and death from severe acute stroke. Neurology 1997;49:1090-1095.
17. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
18. Akim AM. Ischemic penumbra: The therapeutic window. Neurology 1998;513:S44-S46.
19. Ginsberg MD, Pulsinelli WD. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol 1994;36:553-554.
20. Ringelstein EB, Binick R, Weiler C, Ammeling B, Nolte PB, Thron A. Type and extent of hemispheric brain infarctions and clinical outcomes in early and delayed middle cerebral artery recanalization. Neurology 1992;42:289-298.
21. Bozzao L, Fantozzi LM, Bastianello S, Fieschi C. Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke 1989;20:735-740.
22. Fieschi C, Bozzao L. Transient embolic occlusion of the middle cerebral and internal carotid arteries in cerebral apoplexy. J Neurol Neurosurg Psychiatry 1969;32:236-240.
23. Yamaguchi T, Minematsu K, Choiki J, Ikeda M. Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984;48:50-58.
24. Zervas NT, Liszczak TM, Mayberg MR. Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 1982;56:475-481.
25. Fenstemacher JD, Patiak CS, Levin VA, Rall DP. The permeability of brain cells and capillaries to various water-soluble molecules as determined by ventriculocisternal perfusion. Fed Proc 1969;28:578-578.
26. Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a 'Paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Research 1985;326:47-63.
27. Rennels ML, Blaumanis R, Grady PA. Rapid solute transport throughout the brain via paravascular fluid pathways. Advances in Neurology 1990;52:431-439.
28. Bell RD, Osterholm JL, Duckett SW, Anderchek K, Gorsuch PL, Schneider LA. Reduction in cerebral infarction by ventriculocisternal perfusion with oxygenated perfluorooctylbromide. In: Ginsberg MD, Dietrich WD. eds. 16th Princeton Conference on Cerebrovascular Disease. New York: Raven Press, 1989:265-271
29. Bell RD, Frazer GD, Osterholm JL, Duckett SW. A novel treatment for ischemic cerebral hypertension in cats. Stroke 1991;22:80-83.
30. Bose B, Osterholm JL, Triolo AJ. Focal cerebral ischemia: reduction in size of infarcts by ventriculo-subarachnoid perfusion with fluorocarbon emulsion. Brain Res. 1985;311:223-231.
31. Bose B, Osterholm JL, Payne JB, Chambers K. Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion. Neurosurgery 1986;18:270-276.
32. Frazer GD, Bell RD, Gzesh DJ, Osterholm JL. Ventriculo-cisternal perfusion: a technique for brain hypothermia. Neurology 1991;41:346.
33. Bose B, Osterholm JL, Berry R. A reproducible experimental model of focal cerebral ischemia in the cat. Brain Res. 1984;311:385-391.
34. Osterholm JL, Alderman JB, Triolo AJ, D'Amore BR, Williams HD, Frazer G. Severe cerebral ischemia treatment by ventriculo-subarachnoid perfusion with an oxygenated fluorocarbon emulsion. Neurosurgery 1983;13:381-387.
35. Bell RD, Frazer GD, Brock DG, et al. Reduction of cerebral infarction using the third circulation. Crit Care Med 2002;30:2684-2688.
36. Brott TG, Adams HP, Olinger CP, et al. Measurement of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870.
37. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically indentifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
38. Moulin T, Cattin F, Crepin-Leblond T, et al. Early CT signs in acute middle cerebral artery infarction. Neurology 1996;47:336-375.
39. Hacke W, Schwab S, Horn M, Spranger M, DeGeorgia M, VonKummer R. Malignant middle cerebral territory infarction. Arch Neurol. 1996;53:309-315.
40. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Neurology 1998;50:341-350.
41. Sacco RL, Boden-Albala B, Chen X, Lin I-F, Kargman DE, Paik MC. Relationship of 6-month functional outcome and stroke severity: Implications for acute stroke trials from the Northern Manhattan Stroke Study. Neurology 1998;50:S39.002.
42. Adams HP, Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment. Neurology 1999;53:126-131.
43. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-65.
44. Teasdale G, Knill-Jones R, van der Sande J. Observer variability in assessing impaired consciousness and coma. J Neurol Neurosurg Psychiatry 1978;41:603-610.
45. vanSwieten JC, Koudstaal PJ, Visser MC, Schouten HJA, vanGijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
46. Aucoin PJ, Kotilainen HR. Gantz NM. intracranial pressure monitors. epidemiologic study of risk factors and infections. Am J Med 1986;80:369-376.
47. Rosner MJ, Becker DP. ICP monitoring: complications and associated factors. Clin Neurosurg 1976;23:494-519.
48. Frazer GD, Kramer MS, Osterholm JL, Benitez RP, Rosenwasser RH. Rapid removal of subarachnoid blood in sheep by ventriculo-lumbar perfusion of an artificial CSF with and without a thrombolytic. AANS/CNS Section on Cerebrovascular Surgery, Phoenix, AZ, Feb. 16-19, 2003.